1. Home
  2. HFFG vs QNCX Comparison

HFFG vs QNCX Comparison

Compare HFFG & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HF Foods Group Inc.

HFFG

HF Foods Group Inc.

HOLD

Current Price

$2.60

Market Cap

124.7M

ML Signal

HOLD

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

HOLD

Current Price

$4.24

Market Cap

139.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HFFG
QNCX
Founded
1997
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Food Distributors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
124.7M
139.2M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
HFFG
QNCX
Price
$2.60
$4.24
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.75
AVG Volume (30 Days)
77.9K
1.1M
Earning Date
11-10-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,225,541,000.00
N/A
Revenue This Year
$4.36
N/A
Revenue Next Year
$3.35
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.10
N/A
52 Week Low
$1.70
$0.72
52 Week High
$4.93
$4.55

Technical Indicators

Market Signals
Indicator
HFFG
QNCX
Relative Strength Index (RSI) 55.07 75.56
Support Level $2.54 $3.74
Resistance Level $2.79 $4.30
Average True Range (ATR) 0.12 0.46
MACD 0.02 0.10
Stochastic Oscillator 55.67 86.67

Price Performance

Historical Comparison
HFFG
QNCX

About HFFG HF Foods Group Inc.

HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, seafood, frozen and dry food, and non-food products to Asian restaurants and other food service customers throughout the United States. The company's business consists of one operating segment; HF Group, which operates solely in the United States. The company's customer base consists of Chinese and Asian restaurants, and it provides sales and service support to customers who mainly converse in Mandarin or Chinese dialects.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Share on Social Networks: